PSA Testing Guidelines
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
Clinical Pearls
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
- Rather than focus on one guideline or another, physicians should focus on a model of informed decision making
- A dichotomy exists between those that treat prostate cancer and those that do not
- PSA testing adds value but also brings a potential for harm
- Following PSA testing, a physician should be open to the concept of surveillance before making a decision
Recent Videos
Related Content
Conservative Management Is on the Rise in Intermediate-Risk Prostate Cancer
January 17th 2025Article
In an interview with Peers & Perspectives in Oncology, Michael S. Leapman, MD, MHS, discusses the significance of a 10-year rise in active surveillance and watchful waiting in patients with intermediate-risk prostate cancer.
Read More
